-
Hyperthermia Enhances PARP Inhibitor Sensitivity in BRCA2-Pr
2026-07-20
Mei et al. (2025) demonstrate that hyperthermia-induced reduction of BRCA2 protein overcomes intrinsic resistance to PARP inhibitors in BRCA2-proficient ovarian carcinoma models. These findings reveal a mechanistic pathway for sensitizing otherwise resistant tumors and support the development of combination therapies targeting DNA repair.
-
Oseltamivir Acid: Influenza Neuraminidase Inhibitor in Trans
2026-07-20
Oseltamivir acid is a benchmark influenza neuraminidase inhibitor, uniquely positioned for both antiviral and oncology research. This guide delivers advanced workflows, practical troubleshooting, and the latest protocol innovations—powering rigorous influenza antiviral research and beyond.
-
Shufeng Xingbi Therapy Modulates Immune and Microbiota Balan
2026-07-19
This study investigates Shufeng Xingbi Therapy’s (SFXBT) impact on Th1/Th2 immune balance and intestinal flora in a rat model of allergic rhinitis. The findings demonstrate that SFXBT alleviates inflammation, shifts immune signaling, and beneficially remodels gut microbiota, providing mechanistic insights relevant to immune–microbiome research.
-
Chlorin e6 (Ce6) in Photodynamic Therapy: Lab-Ready Workflow
2026-07-18
This article delivers practical, evidence-driven guidance for deploying Chlorin e6 (Ce6; SKU B8314) in modern photodynamic therapy workflows. Drawing on data-backed scenarios, it addresses protocol optimization, data reproducibility, and supplier reliability—helping researchers achieve consistent, high-impact results with Ce6 photosensitizer.
-
Nicotinamide Adenine Dinucleotide (NAD+): Precision Tools fo
2026-07-17
Explore the advanced roles of Nicotinamide Adenine Dinucleotide (NAD+) in dissecting metabolic signaling and DNA damage response. This article delivers a unique, practical guide for leveraging NAD+ in next-generation stress adaptation assays and translational research.
-
Nuclear cGAS-CHK2-TRIM41 Axis Restricts L1 Retrotranspositio
2026-07-17
This study reveals that nuclear cGAS suppresses LINE-1 (L1) retrotransposition in human cells by promoting TRIM41-mediated ubiquitination and degradation of ORF2p, a key L1 protein. Phosphorylation of cGAS by CHK2 is essential for this process, linking DNA damage signaling to retrotransposon control and highlighting new avenues for genome stability research.
-
Electrical Stimulation Enhances Nanoparticle Uptake in Cance
2026-07-16
This study demonstrates that alternating current (AC) electrical stimulation significantly increases the endocytosis of magnetic nanoparticles (MNPs) by various cancer cell types. The findings offer a broadly applicable, non-chemical strategy to improve the effectiveness of nanoparticle-based therapies and imaging.
-
5-(N,N-dimethyl)-Amiloride Hydrochloride: Precision NHE Inhi
2026-07-16
5-(N,N-dimethyl)-Amiloride hydrochloride is a potent Na+/H+ exchanger inhibitor with high selectivity for NHE1, NHE2, and NHE3. It is widely used in intracellular pH regulation and cardiac injury research, offering benchmarked performance and robust workflow protocols. APExBIO supplies this reagent as a crystalline hydrochloride salt for reliable experimental reproducibility.
-
miR-24-3p Regulates Heart Failure via Sp1/PI3K Signaling Axi
2026-07-15
This article examines recent findings that identify miR-24-3p as a key regulator of cardiac dysfunction in doxorubicin-induced heart failure, acting through direct targeting of the Sp1/PI3K signaling pathway. The research highlights both mechanistic insights and potential therapeutic implications for heart failure models.
-
BRCAness and Olaparib Susceptibility in Malignant Mesothelio
2026-07-15
Borchert et al. (2019) systematically link homologous recombination repair (HRR) gene expression—specifically, BRCAness phenotypes—to enhanced susceptibility to olaparib in malignant pleural mesothelioma (MPM) cell lines. Their findings introduce actionable biomarkers and rationalize tailored therapeutic strategies for MPM, with implications for integrating DNA repair profiling into cancer chemotherapy research.
-
GST and Diethylmaleate: Unraveling Insecticide Resistance Me
2026-07-14
This study demonstrates that glutathione S-transferase (GST) upregulation confers resistance to lambda-cyhalothrin in Megalurothrips usitatus by bolstering antioxidant defenses. GST inhibition with diethyl maleate restores insecticide sensitivity, clarifying adaptive redox strategies and informing resistance management.
-
Sulfo-Cy5 Carboxylic Acid: Fluorescent Dye for Life Sciences
2026-07-14
Sulfo-Cy5 carboxylic acid offers exceptional water solubility and minimal quenching, making it indispensable for quantitative fluorescence imaging and advanced protein labeling in aqueous environments. Its role in mucosal immunity and neuroscience research sets a new standard for sensitivity and reproducibility in the life sciences.
-
MLN2238: Protocol Innovations for Proteasome β5 Subunit Inhi
2026-07-13
MLN2238 transforms proteasome β5 subunit inhibitor workflows by enabling precise, potent, and reversible 20S proteasome targeting, even in bortezomib-resistant models. This guide translates cutting-edge discoveries—especially the ROS/JNK/CREB axis—into actionable protocols for oncology and proteostasis research.
-
Sodium Ascorbate: Applied Workflows for Cancer Cell Research
2026-07-13
Sodium Ascorbate, a mineral salt of ascorbic acid, empowers selective induction of reactive oxygen species and necrotic tumor cell death. This article details practical protocols, troubleshooting strategies, and advanced applications for leveraging Sodium Ascorbate in glioblastoma and prostate cancer models.
-
Fluorescein TSA Fluorescence System Kit: Amplifying Detectio
2026-07-12
The Fluorescein TSA Fluorescence System Kit delivers unmatched sensitivity for localizing low-abundance proteins and nucleic acids across IHC, ICC, and ISH workflows. Leverage tyramide signal amplification to push the limits of fluorescence detection, driven by robust protocol design and expert troubleshooting support.